Original language | English (US) |
---|---|
Pages (from-to) | 2432-2446 |
Number of pages | 15 |
Journal | Journal of the American College of Cardiology |
Volume | 58 |
Issue number | 23 |
DOIs | |
State | Published - Nov 29 2011 |
Keywords
- AHA Scientific Statements
- coronary disease
- risk factors
- secondary prevention
- vascular disease
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of the American College of Cardiology, Vol. 58, No. 23, 29.11.2011, p. 2432-2446.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease
T2 - 2011 update
AU - Smith, Sidney C.
AU - Benjamin, Emelia J.
AU - Bonow, Robert O.
AU - Braun, Lynne T.
AU - Creager, Mark A.
AU - Franklin, Barry A.
AU - Gibbons, Raymond J.
AU - Grundy, Scott M.
AU - Hiratzka, Loren F.
AU - Jones, Daniel W.
AU - Lloyd-Jones, Donald M.
AU - Minissian, Margo
AU - Mosca, Lori
AU - Peterson, Eric D.
AU - Sacco, Ralph L.
AU - Spertus, John
AU - Stein, James H.
AU - Taubert, Kathryn A.
N1 - Funding Information: Reviewer Disclosures Reviewer Employment Research Grant Other Research Support Speaker's Bureau/ Honoraria Expert Witness Ownership Interest Consultant/Advisory Board Other Elliott M. Antman Brigham & Women's Hospital None None None None None None None Jeffrey L. Anderson Intermountain Medical Center None None None None None AstraZeneca * None Gary J. Balady Boston Medical Center None None None None None None None Eric R. Bates University of Michigan None None None None None AstraZeneca * ; Daiichi Sankyo * ; Eli Lilly * ; Merck * ; Sanofi Aventis * None Vera Bittner University of Alabama at Birmingham Clinical site PI for multicenter trials funded by: Roche/Genentech † ; Gilead; GSK † ; NIH/Abbott † ; NIH/Yale † None None None None Roche/Genentech * ; Amarin * ; Pfizer * None Ann F. Bolger University of California, San Francisco None None None None None None None Victor A. Ferrari University of Pennsylvania None None None None None Board of Trustees, Society for Cardiovascular Magnetic Resonance (no monetary value) * ; Editorial Board, Journal of Cardiovascular Magnetic Resonance (no monetary value) * None Stephan Fihn Department of Veterans Affairs and University of Washington None None None None None None None Gregg Fonarow UCLA NHLBI † ; AHRQ † None None None None Novartis † ; Medtronic * None Federico Gentile Centro Medico diagnostic, Naples-Italy None None None None None None None Larry B. Goldstein Duke University None None None None None None None Jonathan Halperin Mount Sinai Medical Center None None None None None Boehringer Ingelheim † ; Astellas Pharma, US * ; Bristol-Myers Squibb * ; Daiichi Sankyo * ; Johnson & Johnson * ; Pfizer, Inc * ; Sanofi-Aventis * None Courtney Jordan University of Minnesota None None None None None None None Noel Bairey Merz Cedars-Sinai Medical Center Gilead † NHLBI † Mayo Foundation * ; SCS Healthcare † ; Practice Point Communications * ; Inst for Professional Education * ; Medical Education Speakers Network * ; Minneapolis Heart Institute * ; Catholic Healthcare West * ; Novant Health * ; HealthScience Media Inc * ; Huntsworth Health * ; WomenHeart Coalition * ; Los Robles Medical Center * ; Monterrey Community Hospital (honorarium, donated to ACC) * ; Los Angeles OB-GYN Society * ; Pri-Med * ; North American Menopause Society * None Medtronic † UCSF * ; Society for Women's Health Research * ; Interquest * ; Dannemiller * ; Navvis & Co * ; Springer SBM LLC * ; Duke * ; NHLBI * ; Italian National Institutes of Health * ; Gilead * None L. Kristin Newby Duke University None None None None None None None Patrick O'Gara Brigham & Women's Hospital None None None None None Lantheus Medical Imaging * None Thomas W. Rooke Mayo Clinic None None None None None Merck–Adjudication (Event) Committee * None Vincent Sorrell University of Arizona None None Lantheus Medical Imaging † None None None None
PY - 2011/11/29
Y1 - 2011/11/29
KW - AHA Scientific Statements
KW - coronary disease
KW - risk factors
KW - secondary prevention
KW - vascular disease
UR - http://www.scopus.com/inward/record.url?scp=81855224663&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=81855224663&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2011.10.824
DO - 10.1016/j.jacc.2011.10.824
M3 - Article
C2 - 22055990
AN - SCOPUS:81855224663
SN - 0735-1097
VL - 58
SP - 2432
EP - 2446
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 23
ER -